{"groups":[{"description":"Fludarabine 30 mg/m\\^2 intravenous (IV) for 4 Days + Melphalan 140 mg/m\\^2 IV for 1 Day + Rituximab 375 mg/m\\^2 IV once weekly + Cord Blood Transplantation + Stem Cell Transplantation Infusion","id":"FG000","title":"Cellular Therapy With Cord Blood Cells"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"30"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"30"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"preAssignmentDetails":"One participant of the 31 was enrolled but did not receive treatment.","recruitmentDetails":"Recruitment Period: January 05, 2007 to November 05, 2010. All recruitment done at UT MD Anderson Cancer Center."}